400μG Oral Misoprostol Versus 0.2 Mg Intravenous Methyl Ergometrine For The Active Management Of Third Stage Of Labour
dc.contributor.author | Harshita S | |
dc.date.accessioned | 2013-06-19T09:44:55Z | |
dc.date.accessioned | 2024-03-19T06:20:13Z | |
dc.date.available | 2013-06-19T09:44:55Z | |
dc.date.available | 2024-03-19T06:20:13Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | https://idr.informaticsglobal.com/handle/123456789/108225 | |
dc.language | English | |
dc.publisher | * | |
dc.subject | Postpartum hemorrhage | |
dc.subject | Misoprostol | |
dc.subject | ergometrine | |
dc.title | 400μG Oral Misoprostol Versus 0.2 Mg Intravenous Methyl Ergometrine For The Active Management Of Third Stage Of Labour | |
dc.type | Thesis |